Orforglipron for treating obstructive sleep apnoea associated with obesity or overweight [TSID12323]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Retatrutide for managing overweight and obesity [ID6644]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Semaglutide 7.2 mg single-dose device for managing overweight and obesity [TSID12324]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Tirzepatide for managing overweight and obesity in people 12 to 17 years [TSID12322]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC